|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
2001-3-14
|
|
pubmed:abstractText |
Smoking is associated with a decreased risk of primary sclerosing cholangitis. We aimed to explore the therapeutic efficacy of and tolerance for transdermal nicotine treatment in this disease.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Feb
|
|
pubmed:issn |
0954-691X
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
13
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
171-5
|
|
pubmed:dateRevised |
2009-10-16
|
|
pubmed:meshHeading |
pubmed-meshheading:11246617-Administration, Cutaneous,
pubmed-meshheading:11246617-Adult,
pubmed-meshheading:11246617-Biological Markers,
pubmed-meshheading:11246617-Cholangitis, Sclerosing,
pubmed-meshheading:11246617-Cross-Over Studies,
pubmed-meshheading:11246617-Double-Blind Method,
pubmed-meshheading:11246617-Female,
pubmed-meshheading:11246617-Humans,
pubmed-meshheading:11246617-Male,
pubmed-meshheading:11246617-Nicotine,
pubmed-meshheading:11246617-Nicotinic Agonists,
pubmed-meshheading:11246617-Ursodeoxycholic Acid
|
|
pubmed:year |
2001
|
|
pubmed:articleTitle |
No beneficial effects of transdermal nicotine in patients with primary sclerosing cholangitis: results of a randomized double-blind placebo-controlled cross-over study.
|
|
pubmed:affiliation |
Department of Hepatology and Gastroenterology, University Hospital, Rotterdam, The Netherlands.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|
